miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells
Authors Li X, Li Y, Wan L, Chen R, Chen F
Received 15 December 2016
Accepted for publication 9 June 2017
Published 11 September 2017 Volume 2017:10 Pages 4455—4464
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Akshita Wason
Peer reviewer comments 3
Editor who approved publication: Dr Chiung-Kuei Huang
Xin Li,1 Yan Li,2 Li Wan,3 Rui Chen,4 Fei Chen5
1Department of Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 2Department of Ophthalmology and Otorhinolaryngology, Lecong Hospital of Guangzhou Medical University, Foshan, 3Department of Laboratory Medicine, The Fourth Affiliated Hospital of Guangzhou Medical University, 4Key Laboratory for Major Obstetric Diseases in Guangdong Province, Key Laboratory of Reproduction and Genetics in Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, 5Department of Histology and Embryology, School of Basic Sciences, Guangzhou Medical University, Guangzhou, People’s Republic of China
Objective: This study aimed to explore the effect of miR-509-5p on pancreatic cancer progression and clarify the underlying mechanisms.
Methods: Real-time quantitative reverse transcription polymerase chain reaction was employed to determine miR-509-5p expression in pancreatic cancer tissues and noncancerous adjacent tissues. CCK-8 and Transwell experiments were employed to examine cellular proliferation, migration, and invasion after miR-509-5p mimic or inhibitor transfection. Bioinformatics tools were used to identify the target gene of miR-509-5p, and cotransfection of the target gene and miR-509-5p mimic was performed to determine the effect on the proliferation and migration of pancreatic cancer cells. A xenograft mouse model and histological analysis were also used to test the effect of miR-509-5p on tumor growth in vivo.
Results: miR-509-5p expression was dramatically downregulated in pancreatic cancer tissues and in pancreatic cancer cell lines. miR-509-5p mimic markedly inhibited PANC-1 cell proliferation, migration, and invasion. Conversely, miR-509-5p inhibitor promoted PANC-1 cell proliferation, migration, and invasion. Furthermore, the 3'UTR–specific target site luciferase reporter assay also showed that miR-509-5p negatively regulated MDM2 at the post-transcriptional level. miR-509-5p effectively reversed the MDM2 overexpression-induced increase in PANC-1 cell proliferation and invasion. Moreover, miR-509-5p inhibited tumor growth and accelerated cell death in the tumor samples.
Conclusions: Our results suggested that miR-509-5p served as a new tumor suppressor via targeting the MDM2 gene, inhibiting pancreatic cancer progression.
Keywords: miR-509-5p, pancreatic cancer, MDM2, proliferation, migration, invasion
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]